Abstract
Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Current Respiratory Medicine Reviews
Title:Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Volume: 12 Issue: 1
Author(s): Arthur L. Frank
Affiliation:
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Abstract: Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Export Options
About this article
Cite this article as:
Frank L. Arthur, Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151026222515
DOI https://dx.doi.org/10.2174/1573398X11666151026222515 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases
CNS & Neurological Disorders - Drug Targets Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Anti-Cancer Agents in Medicinal Chemistry Concentrations of Cd, Cu, Pb and Zn in Blood Serum of Cancer Patients and Comparison with Healthy Person by Atomic Absorption Spectrometry
Current Analytical Chemistry Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens
Current Stem Cell Research & Therapy Naturally-occurring Dimers of Flavonoids as Anticarcinogens
Anti-Cancer Agents in Medicinal Chemistry Potential Roles of Eosinophils in Cancer Therapy: Epidemiological Studies, Experimental Models, and Clinical Pathology
Recent Patents on Anti-Cancer Drug Discovery Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Anti-Cancer Agents in Medicinal Chemistry Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Alterations in Homocysteine Metabolism Among Alcohol Dependent Patients - Clinical, Pathobiochemical and Genetic Aspects
Current Drug Abuse Reviews DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Regulative Roles of Ghrelin in Ingestive Behavior, Upper Gastrointestinal Motility, and Secretion
Current Nutrition & Food Science Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer: Our Experience and Review of Literature
Mini-Reviews in Medicinal Chemistry Thyroid Cancer and Nodules in Graves’ Disease: A Single Center Experience
Endocrine, Metabolic & Immune Disorders - Drug Targets In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry